I know the are a few thoughts out there that strictly targeting T-cells is incomplete. I haven't kept up on the Rituxan trials but received an e-mail today from the Myelin Repair Foundation (that' probably not exactly right) and there seem to be some good results.....except for the death thing. So is it time to look forward to the Tovaxin/Rituxan cocktail? Thoughts on the Rituxan trial? Anyone?
Lars